BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 8768845)

  • 1. Extensive mutation scanning of RET in sporadic medullary thyroid carcinoma and of RET and VHL in sporadic pheochromocytoma reveals involvement of these genes in only a minority of cases.
    Hofstra RM; Stelwagen T; Stulp RP; de Jong D; Hulsbeek M; Kamsteeg EJ; van den Berg A; Landsvater RM; Vermey A; Molenaar WM; Lips CJ; Buys CH
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2881-4. PubMed ID: 8768845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sporadic pheochromocytomas are rarely associated with germline mutations in the vhl tumor suppressor gene or the ret protooncogene.
    Brauch H; Hoeppner W; Jähnig H; Wöhl T; Engelhardt D; Spelsberg F; Ritter MM
    J Clin Endocrinol Metab; 1997 Dec; 82(12):4101-4. PubMed ID: 9398721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consequences of direct genetic testing for germline mutations in the clinical management of families with multiple endocrine neoplasia, type II.
    Neumann HP; Eng C; Mulligan LM; Glavac D; Zäuner I; Ponder BA; Crossey PA; Maher ER; Brauch H
    JAMA; 1995 Oct; 274(14):1149-51. PubMed ID: 7563486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Genetic tests in oncology practice with emphasis on the RET oncogene and VHL tumor suppressor gene].
    Nesković G; Stanojević B; Palmar I; Dimitrijević B
    Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():52-7. PubMed ID: 12584999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular genetic diagnosis of von Hippel-Lindau disease in familial phaeochromocytoma.
    Crossey PA; Eng C; Ginalska-Malinowska M; Lennard TW; Wheeler DC; Ponder BA; Maher ER
    J Med Genet; 1995 Nov; 32(11):885-6. PubMed ID: 8592333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic predisposition to phaeochromocytoma: analysis of candidate genes GDNF, RET and VHL.
    Woodward ER; Eng C; McMahon R; Voutilainen R; Affara NA; Ponder BA; Maher ER
    Hum Mol Genet; 1997 Jul; 6(7):1051-6. PubMed ID: 9215674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatic mutations of the ret protooncogene in sporadic medullary thyroid carcinoma are not restricted to exon 16 and are associated with tumor recurrence.
    Romei C; Elisei R; Pinchera A; Ceccherini I; Molinaro E; Mancusi F; Martino E; Romeo G; Pacini F
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1619-22. PubMed ID: 8636377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rudolf-Virchow-Preis 1995. The role of RET proto-oncogene mutation analysis in the diagnosis of multiple endocrine neoplasia type 2 (MEN 2) gene carriers and in the discrimination of sporadic and familial medullary thyroid carcinomas and pheochromocytomas.
    Komminoth P
    Verh Dtsch Ges Pathol; 1995; 79():L-LV. PubMed ID: 8600671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Germ-line mutations in nonsyndromic pheochromocytoma.
    Neumann HP; Bausch B; McWhinney SR; Bender BU; Gimm O; Franke G; Schipper J; Klisch J; Altehoefer C; Zerres K; Januszewicz A; Eng C; Smith WM; Munk R; Manz T; Glaesker S; Apel TW; Treier M; Reineke M; Walz MK; Hoang-Vu C; Brauckhoff M; Klein-Franke A; Klose P; Schmidt H; Maier-Woelfle M; Peçzkowska M; Szmigielski C; Eng C;
    N Engl J Med; 2002 May; 346(19):1459-66. PubMed ID: 12000816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential genetic alterations in von Hippel-Lindau syndrome-associated and sporadic pheochromocytomas.
    Bender BU; Gutsche M; Gläsker S; Müller B; Kirste G; Eng C; Neumann HP
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4568-74. PubMed ID: 11134110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pheochromocytoma in von Hippel-Lindau disease and neurofibromatosis type 1.
    Opocher G; Conton P; Schiavi F; Macino B; Mantero F
    Fam Cancer; 2005; 4(1):13-6. PubMed ID: 15883705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in the RET proto-oncogene and the von Hippel-Lindau disease tumour suppressor gene in sporadic and syndromic phaeochromocytomas.
    Eng C; Crossey PA; Mulligan LM; Healey CS; Houghton C; Prowse A; Chew SL; Dahia PL; O'Riordan JL; Toledo SP
    J Med Genet; 1995 Dec; 32(12):934-7. PubMed ID: 8825918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sporadic phaeochromocytomas are rarely associated with germline mutations in the von Hippel-Lindau and RET genes.
    Bar M; Friedman E; Jakobovitz O; Leibowitz G; Lerer I; Abeliovich D; Gross DJ
    Clin Endocrinol (Oxf); 1997 Dec; 47(6):707-12. PubMed ID: 9497878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Germline mutations in the vhl gene in patients presenting with phaeochromocytomas.
    van der Harst E; de Krijger RR; Dinjens WN; Weeks LE; Bonjer HJ; Bruining HA; Lamberts SW; Koper JW
    Int J Cancer; 1998 Jul; 77(3):337-40. PubMed ID: 9663592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic aspects of pheochromocytoma.
    Koch CA; Vortmeyer AO; Huang SC; Alesci S; Zhuang Z; Pacak K
    Endocr Regul; 2001 Mar; 35(1):43-52. PubMed ID: 11308996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation analysis of the c-mos proto-oncogene and the endothelin-B receptor gene in medullary thyroid carcinoma and phaeochromocytoma.
    Eng C; Foster KA; Healey CS; Houghton C; Gayther SA; Mulligan LM; Ponder BA
    Br J Cancer; 1996 Aug; 74(3):339-41. PubMed ID: 8695346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RET proto-oncogene point mutations in sporadic neuroendocrine tumors.
    Komminoth P; Roth J; Muletta-Feurer S; Saremaslani P; Seelentag WK; Heitz PU
    J Clin Endocrinol Metab; 1996 Jun; 81(6):2041-6. PubMed ID: 8964826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel point mutations and allele loss at the RET locus in sporadic medullary thyroid carcinomas.
    Uchino S; Noguchi S; Adachi M; Sato M; Yamashita H; Watanabe S; Murakami T; Toda M; Murakami N; Yamashita H
    Jpn J Cancer Res; 1998 Apr; 89(4):411-8. PubMed ID: 9617347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Von Hippel-Lindau gene alterations in sporadic benign and malignant pheochromocytomas.
    Dannenberg H; De Krijger RR; van der Harst E; Abbou M; IJzendoorn Y; Komminoth P; Dinjens WN
    Int J Cancer; 2003 Jun; 105(2):190-5. PubMed ID: 12673678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation analysis of glial cell line-derived neurotrophic factor (GDNF), a ligand for the RET/GDNF receptor alpha complex, in sporadic phaeochromocytomas.
    Dahia PL; Toledo SP; Mulligan LM; Maher ER; Grossman AB; Eng C
    Cancer Res; 1997 Jan; 57(2):310-3. PubMed ID: 9000574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.